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Endoplasmic reticulumChalcones, naturally occurring open-chain ﬂavonoids abundant in plants, have demonstrated anticancer
activity in multiple tumor cells. In a previous work, the potential anticancer activity of three naphthyl-
chalcones named R7, R13 and R15 was shown. In this study, the mechanism of actions of these chalcones
was originally shown. The chalcones presented concentration and time-dependent cytotoxicity. To deter-
mine the type of cell death induced by chalcones, we assessed a series of assays including measurements
of the caspase-8, -9 and -12 activities, expression of important apoptosis-related genes and proteins,
changes in the cell calcium concentration and cytochrome c release. The activities of caspase-8, -9 and
-12 increased after the treatment of L1210 cells with the three compounds. Chalcones R7 and R13
induced an increase of pro-apoptotic proteins Bax, Bid and Bak (only chalcone R13), as well as a decrease
in anti-apoptotic Bcl-2 expression. These chalcones also induced an increase in Fas and a decrease in p21
and p53 expression. Chalcone R15 seems to act by a different mechanism to promote cell death, as it did
not change the mitochondrion-related proteins, nor did it induce the cytochrome c release. All com-
pounds induced an increase in cell calcium concentration and an increase in CHOP expression, which
together with an increase in caspase-12 activity, suggest that chalcones could induce an endoplasmic
reticulum (ER) stress. Taken together, these results suggest that chalcones induce apoptosis by different
pathways, being an interesting strategy to suggest for cancer therapy.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Cancer is a leading cause of death worldwide and the World
Health Organization estimates that by 2030 there will be 13 mil-
lion cancer related deaths. Acute lymphoblastic leukemia (ALL) is
a malignant disorder that can originate from one single hematopoi-
etic precursor committed to the B- or the T-cell lineage. Acquisition
by the precursor of a series of genetic abnormalities in its normal
maturation process can cause differentiation arrest and prolifera-
tion of the immature cell (Graux, 2011). ALL has a peak prevalence
between the ages of two and ﬁve years, and is the most common
form of childhood cancer (Faderl et al., 2003).
Childhood ALL can be successfully treated with multiple-agent
chemotherapy, but many patients still develop serious acute and/or late complications due to the side effects of the drugs. Studies
have shown that the risk of death from cardiac causes or other
forms of cancer is higher in ALL survivors (Diller, 2011; Faderl
et al., 2003; Mertens et al., 2008; Reulen et al., 2010). In addition,
children with ALL are at risk of low bone mineral density as a result
of the high doses of glucocorticoids and intrathecal methotrexate
included in almost every ALL treatments (Kaste et al., 2006;
Thomas et al., 2008).
Aberrant regulation of apoptosis mechanisms is an important
pathological factor in a variety of major human diseases. Failure
to appropriately engage this pathway is one of the hallmarks of
cancer development, and many cancer cells exhibit signiﬁcant
resistance to apoptosis signaling (Sayers, 2011).
In mammalian cells, apoptosis occurs through two distinct
molecular pathways, which are regulated by caspases. The intrinsic
or mitochondrial pathway is activated by intracellular events, and
depends on the release of pro-apoptotic and anti-apoptotic factors
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cytochrome c and APAF-1, among others. The extrinsic pathway
is initiated by the binding of an extracellular death ligand to its
cell-surface death receptor (Kiechle and Zhang, 2002; Riedl and
Shi, 2004). The extrinsic pathway can crosstalk to the intrinsic
pathway through the caspase-8-mediated cleavage of BID
(a member of the Bcl2 family of proteins) (Billen et al., 2008).
The endoplasmic reticulum (ER) is an essential intracellular
organelle, and in conjunction with Ca2+, plays a vital role in the
synthesis, folding and post-translational modiﬁcation of proteins.
If the ER becomes overwhelmed, either due to a problem with pro-
tein folding or by an overproduction of proteins, the cell triggers a
speciﬁc ER stress response mostly resulting in apoptosis through
caspase-12 activation (Berridge, 2002; Groenendyk and Michalak,
2005; Sitia and Braakman, 2003).
Some authors have concluded that because of the alterations’
heterogeneity found in leukemia, new apoptosis-inductive agents
are required, for better efﬁcacy and side effects reduction (Debatin,
2004; Nicholson, 2000; Zhang et al., 2008).
Natural products are the source of most of the active com-
pounds in medicines. More than 80% of drugs are obtained from
natural sources or are based on natural compounds (Harvey,
2008). Chalcones are essential intermediate compounds in ﬂavo-
noid biosynthesis in plants. Many studies have demonstrated
anti-leukemic (Orlikova et al., 2011; Pedrini et al., 2010; Winter
et al., 2010), anti-angiogenic (Kim et al., 2010), anti-infective
(Nowakowska et al., 2008) and hypotensive (Ogawa et al., 2007)
activities for chalcones, among other pharmacological effects.
In a previous work we demonstrated the general effects of
naphthylchalcones R7, R13 and R15 (Fig. 1) on a lymphoblastic leu-
kemia cell line, by monitoring the oxidative stress, and their inﬂu-
ence on energetic metabolism (Winter et al., 2010). In this study it
is being reported the molecular targets, using gene and protein
expression, caspase activities, calcium concentration and cyto-
chrome c release evaluation, Chalcones R7 and R13 triggered apop-
tosis by intrinsic and extrinsic pathways. Moreover, they induced
endoplasmic reticulum stress triggered by changes in intracellular
calcium concentration. The apoptosis induced by Chalcone R15 did
not seem to be related to the mitochondrion, and was triggered by
extrinsic pathway and ER stress.2. Materials and methods
2.1. Chemicals
The cell culture medium was purchased from Cultilab (São Pau-
lo, SP). Serum and antibiotics were purchased from GIBCO (Grand
Island, NY). The ApopNexin™ FITC Apoptosis Detection Kit was
purchased from Millipore (Billerica, MA); the DNase I, TRIZOL re-
agent and the primers were purchased from Invitrogen (Carlsbad,
CA); the High-Capacity cDNA Reverse Transcription Kit and the
Power SYBR-Green PCR Master Mix were purchased from Applied
Biosystems (Foster City, CA); the ﬂuorogenic substrate caspase-
12 was purchased from Biovision (Milpitas, CA); the Fluo-3AM
was purchased from Biovision (San Francisco, CA); the phycoery-
thrin-conjugated monoclonal antibodies were purchased from BDFig. 1. Chemical structures of napht(Becton Dickinson, Franklin Lakes, NJ) and all other reagents were
purchased from Sigma Chemical Co. (St. Louis, MO). Naphthylchal-
cones R7, R13 and R15 were synthesized as previously described
(Winter et al., 2010).
2.2. Cell culture and treatments
Murine L1210 lymphoblastic leukemia cells, murine ﬁbroblast
(NIH/3T3) and monkey kidney cells (VERO) were obtained from
the American Type Culture Cell (ATCC). L1210 cells were cultured
in RPMI 1640 medium and NIH/3T3 and VERO cells were cultured
in DMEM medium, both supplemented with 10% heat-inactivated
fetal bovine serum, 100 U/ml penicillin, 100 lg/ml streptomycin
and 10 mM HEPES. The cell culture was maintained at 37 C in a
5% CO2 humidiﬁed atmosphere and pH 7.4. Every two days, cells
were passaged by removing 90% of the supernatant and replacing
it with fresh medium. In all experiments, viable cells were checked
at the beginning of the experiment by Trypan Blue exclusion. The
concentration of chalcones used in all experiments were the CC50
of them after 24 h of incubation (concentration of the compounds,
which results in 50% of cell viability). The CC50 values were deter-
mined by MTT method in a previous work (Winter et al., 2010).
Sigmoidal dose–response curves were ﬁtted to plot the percentage
of viable cells versus log of compounds concentrations (0–100 lM)
using GraphPad Prism 5. Chalcone R7 presented a CC50 value of
30 lM and chalcones R13 and R15 presented a CC50 value of
40 lM.
2.3. Calculation of selectivity index (SI)
The selectivity index (SI) corresponds to CC50 of chalcones on
non-tumoral cell lines (VERO and NIH/3T3) divided by CC50 deter-
mined for cancer cells (L1210). A SI higher than one indicate that
the compound is more selective for cancer cells. The CC50 of chal-
cones in all cell lines was calculated after 24 h of incubation
according to the methodology described above.
2.4. Annexin V/PI staining for cell apoptosis
Cell apoptosis was assessed by measuring membrane redistri-
bution of phosphatidylserine using an ApopNexin™ FITC Apoptosis
Detection Kit (Millipore, Billerica, MA), according to the manufac-
turer’s protocol. Brieﬂy, cells (1  106/well) were plated and trea-
ted with the CC50 concentration for each compound, 30 lM of
chalcone R7, 40 lM of chalcones R13 and R15 or solvent control
(DMSO) for 12 h, washed twice with chilled phosphate-buffered
saline (PBS), resuspended in the binding buffer, and stained with
staining solution containing Annexin V-FITC and PI. After incuba-
tion in the dark for 15 min, cells were analyzed by ﬂow cytometer
FACSCanto (Becton Dickinson, Franklin Lakes, NJ) and the results
were analyzed using WinMDI 2.9 software.
2.5. Determination of caspase activities
To determine the activity of caspases, 1  107 L1210 cells were
incubated with the compounds for 4 h at 37 C. Cells were then
washed with PBS and lysed with lysis buffer containing 50 mMhylchalcones R7, R13 and R15.
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ml pepstatin A, 1 lg/ml leupeptin, 5 lg/ml aprotinin, 5 mM 3-
[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate
(CHAPS) and 5 mM dithiothreitol (DTT) at 4–8 C for 10 min. An
aliquot of the extract (about 100 lg of protein) was then added
to a buffer containing 20 mM HEPES pH 7.4, 0.1% CHAPS, 2 mM
EDTA, 5% sucrose and 5 mM DTT. The reaction medium was sup-
plemented with 100 lM of Ac-LEHD-AFC, a ﬂuorogenic substrate
for caspase-9, or with 25 lM of Ac-IETD-AMC, a ﬂuorogenic sub-
strate for caspase-8, or with 25 lM of Ac-ATAD-AFC, a ﬂuorogenic
substrate for caspase-12. After incubation of the lysates with the
respective substrates at 37 C for 2 h, caspases activities were mon-
itored using a spectroﬂuorimeter (Perkin Elmer LS55) by the pro-
duction of ﬂuorescent AMC or AFC. The ﬂuorescence of blanks
containing the cells without ﬂuorescent substrates was subtracted
from the sample values. Protein content was determined using a
spectroﬂuorimeter at 280 nm for excitation and 340 nm for emis-
sion. The caspases activities were presented as a percentage taking
into account the values of ﬂuorescent units per lg of protein.2.6. RNA extration
For RNA isolation, 3  106 L1210 cells were incubated with the
compounds for 4 h at 37 C. Total RNA was prepared using Trizol
reagent (Invitrogen). 0.5 ml of Trizol was added to each tissue sam-
ple and homogenized. Samples were incubated for 5 min at room
temperature, and then an aliquot of chloroform was added. Sam-
ples were further incubated for 2 min at room temperature and
centrifuged at 12,000g for 15 min at 4 C. The upper aqueous
phase was transferred to a RNase-free tube and the RNA was pre-
cipitated by adding an aliquot of isopropanol. The samples were
incubated at room temperature for 10 min and centrifuged at
12,000g for 10 min at 4 C. The resulting RNA pellet was washed
in 75% ethanol and resuspended in RNase-free water.2.7. Real-Time quantitative RT-PCR
The reaction was performed on an ABI Prism 7900 (Applied
Biosystems). In summary, total RNA (2 lg) was used for cDNA
synthesis, according to the manufacturer’s instructions for the
High-Capacity cDNA Reverse Transcription Kit (Applied Biosys-
tems, Foster City, CA, EUA), using random hexamers. This cDNA
was subsequently used for quantitative PCR to quantify the gene
expression levels. Power SYBR-Green PCR Master Mix (Applied
Biosystems) was used to employ quantitative PCR. The sequences
of speciﬁc primers used for each gene studied, including the endog-
enous control GAPDH, are shown in Table 1. Brieﬂy, a reaction con-
tained SYBR GreenPCR Master Mix, forward and reverse primers
(ﬁnal concentration 0.15 lM) and the template cDNA. The PCR
was performed using ABI 7900 at 50 C for 2 min, at 95 C for
10 min, followed by 40 cycles of 95 C for 15 s, and 57 C forTable 1
The Sequence of speciﬁc primers for each gene studied including the endogenous control
Gene Forward primer (50–30)
p21 CTGTCTTGCACTCTGGTGTCT
p53 GTAAACGCTTCGAGATGTTCC
Fas TCTGCGATGAAGAGCATGGTT
Bid GAGATGGACCACAACATCCA
Bax ACAGGGGCCTTTTTGCTAC
Bak TACCTCCACCAGCAGGAAC
Bcl2 AGAGACTCACCAGGGTCTGC
GAPDH GTGTCCGTCGTGGATCTGAC
CHOP GGAAGTGCATCTTCATACACCACC
a GAPDH = Glyceraldehyde-3-phosphate dehydrogenase.1 min. The speciﬁcity of SYBR Green assay is dependent on the
speciﬁcity of the primers used in each reaction. Nonspeciﬁc ampli-
ﬁcation and primer/dimer artifacts must be minimized in order to
obtain accurate results. Thus, a dissociation curve reaction for each
primer pair (95 C for 15 s, 60 C for 20 s and 95 C for 15 s) is
required, and has to be started immediately after the completion
of the real-time PCR run. The gene-speciﬁc product was normal-
ized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
quantiﬁed using the comparative (DCt) Ct method as previously
described (Livak and Schmittgen, 2001).
2.8. Measurement of proteins expression by ﬂow cytometry
The expression levels of the proteins Bcl-2, p53 and Fas were
analyzed by ﬂow cytometry (Becton Dickinson FACSCantoII). In
brief, cells were incubated with the chalcones for 4 and 12 h,
washed with PBS and permeabilized in the BD Cytoﬁx/Cyto-
perm™ Buffer (Becton Dickinson, Franklin Lakes, NJ) for 30 min at
4 C. The cells were washed and resuspended in BD Perm/
Wash™ buffer containing the phycoerythrin-conjugated monoclo-
nal antibodies. Analysis of all the antibodies was carried out sepa-
rately. After 30 min of incubation at 4 C, the cells were washed
and analyzed. Background ﬂuorescence was measured by using
an immunoglobulin isotype control antibody. For the Fas antibody,
the ﬁrst stage of permeabilization was not performed because this
protein is located in the cytoplasmic membrane.
2.9. Measurement of intracellular calcium concentration
The changes in intracellular Ca2+ concentration were deter-
mined by the ﬂuorescent dye, Fluo-3AM (Biovision, San Francisco,
CA). Cells were incubated with chalcones or with A23187 (1 lM), a
calcium ionophore used as positive control, at 37 C for 4 h. In sum-
mary, the cell culture medium was replaced and the cells were
incubated at 37 C for 20 min with a fresh medium containing
3 lM Fluo-3 and 0.02% of Pluronic F127. Four times the volume
of HBSS with 1% of fetal bovine serum was then added, and incu-
bated for a further 40 min. Cells were then washed and analyzed
using a spectroﬂuorimeter. Protein content was determined using
a spectroﬂuorimeter at 280 nm for excitation and 340 nm for emis-
sion. Concentration of intracellular calciumwas expressed as a per-
centage taking into account the values of ﬂuorescent units per lg
of protein.
2.10. Cell cycle analysis
L1210 cells (1  106) were treated with chalcones or Paclitaxel
(1 lM) for 12 h. Cells were washed with cold PBS and resuspended
in 70% ice ethanol to ﬁx them. After 30 min, PBS with 2% bovine
serum albumin was added. The cell pellets were collected by cen-
trifugation, resuspended in hypotonic buffer (0.1% Triton X-100 in(GAPDHa).
Reverse primer (50–30) Product size (bp)
GGCACTTCAGGGTTTTCTCT 149
GACTGGCCCTTCTTGGTCT 123
GCAGCGAACACAGTGTTCACA 121
AGGCTGTCTTCACCTCATCAA 126
GAGACACTCGCTCAGCTTCTT 125
GACCCACCTGACCCAAGA 125
GCACTACCTGCGTTCTCCTC 113
GGAGACAACCTGGTCCTCAG 132
TGACTGGAATCTGGAGAGCGAGGGC 315
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emitted from the PI–DNA complex was quantiﬁed by ﬂow cytom-
etry (FACSCanto, Becton Dickinson), and the results were analyzed
using WinMDI 2.9 software.
2.11. Determination of cytochrome c release
L1210 cells (5  106) were treated with chalcones for 4 h and
then washed with PBS. Cells were harvested and permeabilized
with 30 lmol/l digitonin for 30 min at 4 C in a solution containing
10 mg/ml Tris–HCl (pH 7.0), 3 mg/ml ethylene glycol, tetra-acetic
acid (EGTA) and 50 lg/ml sucrose. The cells were centrifuged at
10,000g for 30 min. Cytochrome c release was evaluated by the
method described by Appaix et al. (2000). The absorbance of the
supernatants was recorded at 414 nm, using the medium as a
blank.
2.12. Statistical analysis
The results were presented as means ± standard error of mean
(SEM) of triplicates from at least three-independent experiments.
Statistical signiﬁcance was assessed by ANOVA followed by Dun-
nett’s test, and a p value less than 0.05 was considered signiﬁcant.3. Results
3.1. Chalcones induced cytotoxicity and cell death by apoptosis
The potential cytotoxicity of naphthylchalcones R7, R13, and
R15 (Fig. 1) in L1210 cells was shown in a previous study by our
group (Winter et al., 2010). These chalcones induced concentration
and time-dependent cytotoxicity with CC50 values after 24 h of
incubation of 30 lM for R7 and 40 lM for R13 and R15. To charac-
terize the cell death induced by the compounds, ﬂow cytometry
analysis with Annexin V/PI staining was employed. Following
FACS, ﬂuorescence of PI was plotted over Annexin V-FITC ﬂuores-
cence (Fig. 2). As shown in Fig. 2a, healthy cells presented low FITC
ﬂuorescence and low PI ﬂuorescence (Q1); early apoptotic cells
presented high FITC ﬂuorescence but low PI ﬂuorescence (Q2); lateFig. 2. Apoptosis induction in L1210 cells by chalcones. The apoptosis was measured by A
with the dyes and analyzed by ﬂow cytometry. The horizontal and vertical axes repres
represents early apoptotic cells (positive for Annexin V only), Q3 represents late apoptot
only). The dot plots shown (a) are representative of one experiment, and the graph (b) s
the control.apoptotic cells presented high FITC ﬂuorescence and high PI ﬂuo-
rescence (Q3); necrotic cells presented low FITC ﬂuorescence but
high PI ﬂuorescence (Q4). As shown in Fig. 2b, the percentage of
apoptotic cells (Q2 + Q3) induced by the chalcones was signiﬁ-
cantly higher than the percentage of necrotic cells (Q4).3.2. Chalcones selectivity
Chalcones presented a selectivity index (SI) higher than one
indicating that chalcones present higher selectivity to leukemic
cells when compared to non-tumoral cells (VERO and NIH/3T3).
The only exception was chalcone R15 that presented the same tox-
icity in L1210 and VERO cells. For a better evaluation of chalcones
toxicity, in vivo studies should be performed (see Table 2).3.3. Chalcones induced apoptosis via an activated caspases-dependent
pathway
Initiators caspases 8 and 9 are closely related to apoptotic sig-
nals. Once activated, these caspases cleave and activate down-
stream effector caspases (including 3, 6, and 7), which in turn
cleave cytoskeletal and nuclear proteins and ﬁnally induce apopto-
sis (Riedl and Shi, 2004). Treatment of leukemic cells with chal-
cones for 4 h resulted in an increase in caspases 3, 8 and 9
activities (Fig. 3).3.4. Chalcones induced gene expression alterations
The effect of the three chalcones on the expression of apoptosis-
related genes such as the death receptor Fas, p21, p53, family-Bcl2
proteins like Bid, Bcl2, Bax and Bak and the transcription factor
CHOP involved in endoplasmic reticulum stress were evaluated.
Chalcones R7 and R13 induced an increase in Fas, Bid and Bax
expression, did not alter the Bak and p53 expression, and de-
creased the p21 and Bcl2 expression. Chalcone R15 showed a dif-
ferent proﬁle because it induced an increase in Fas, did not alter
the Bax, Bak, Bid and Bcl2 expression, and decreased the p53 and
p21 expression. All chalcones induced an increase in CHOP expres-
sion (Fig. 4).nnexin-V-FITC/PI) staining. L1210 cells were treated with chalcones for 12 h, stained
ent labeling with Annexin-V-FITC and PI, respectively. Q1 represents live cells, Q2
ic cells (Annexin-V and PI positives) and Q4 represents necrotic cells (positive for PI
hows the mean ± SEM of three independent experiments. ⁄⁄ p < 0.01 compared with
Table 2
Values of selectivity index (SI) of chalcones.
SI (VERO/L1210) SI (NIH3T3/L1210)
R7 1.7 1.4
R13 1.9 2.2
R15 1.0 1.3
Fig. 3. Activation of caspase-3,-8 and -9 in L1210 cells by chalcones. L1210 cells
were incubated with the compounds for 4 h. Caspases activities were measured by
monitoring the cleavage of Ac-DEVD-AMC, a ﬂuorogenic substrate for caspase-3,
Ac-IETD-AMC, a ﬂuorogenic substrate for caspase-8 and of Ac-LEHD-AFC a
ﬂuorogenic substrate for caspase-9. The activity is given as a percentage of the
control considered 100%. ⁄ p < 0.05 and ⁄⁄ p < 0.01 compared with the control.
Fig. 4. Changes in expression of genes apoptosis-related induced by chalcones. Real
time RT-PCR analyses of CHOP, p53, Fas, Bcl-2, Bak, Bax, Bid and p21 were
performed using 2 lg total RNAs derived from cells treated with the chalcones for
4 h. GAPDH was utilized as endogenous control and the expression level of genes in
untreated cells was designated as 1.0. ⁄ p < 0.05 and ⁄⁄ p < 0.01 compared with the
control.
Fig. 5. Changes in expression of proteins apoptosis-related after incubation with
chalcones. Cells were incubated with chalcones for 4 and 12 h. Analyses of Bcl-2 (a),
p53 (b) and Fas (c) (4, 12 and 24h) performed by ﬂow cytometry using speciﬁc
antibodies. ⁄ p < 0.05 and ⁄⁄ p < 0.01 compared with the control.
E. Winter et al. / Toxicology in Vitro 28 (2014) 769–777 7733.5. Chalcones induced protein expression alterations
To conﬁrm the results obtained with the real time PCR, the pro-
teins Bcl-2, Fas and p53 were analyzed by ﬂow cytometry after
incubation with the compounds for 4 h, 12 h and 24 h (only for
Fas detection). The chalcones R7 and R13 induced a decrease and
the chalcone R15 did not alter the Bcl-2 level, in agreement with
the results obtained from gene expression assay (Fig. 5a). Allchalcones induced a decrease in p53 protein level after 4 h of incu-
bation, but only the R15 had the same effect after 12 h of incuba-
tion in cell culture (Fig. 5b). A decrease in p53 gene expression
was also observed in the results obtained by PCR (Fig. 4). In addi-
tion, the chalcones did not induce statistically signiﬁcant altera-
tions in Fas protein expression after 4 or 12 h of incubation,
however a tendency for the expression of this protein to increase
was observed after 24 h of incubation (Fig. 5c).
3.6. Chalcones induced cytochrome c release from mitochondria
Mitochondrial cytochrome c, which functions as an electron
carrier in the respiratory chain, translocates to the cytosol in cells
undergoing apoptosis, and together with APAF-1 mediates
Fig. 6. Increase in cytochrome c release induced by R7 and R13. Cells were
incubated with the chalcones for 4 h. Cytochrome c was measured spectrophoto-
metrically (414 nm). The results are given as a percentage of the control. ⁄ p < 0.05
and ⁄⁄ p < 0.01 compared with the control.
Fig. 7. Increase in caspase-12 activity and in intracellular calcium concentrations
induced by chalcones. Cells were incubated with the chalcones or with A23187 (as a
positive control for calcium analysis) for 4 h. Caspase-12 activity was measured by
monitoring the cleavage of Ac-ATAD-AFC – a ﬂuorogenic substrate for caspase-12.
Calcium concentration was evaluated by ﬂuorescent dye Fluo-3AM. The results are
given as a percentage of the control. ⁄ p < 0.05 and ⁄⁄ p < 0.01 compared with the
control.
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prevent the efﬂux of cytochrome c from mitochondria. A reduction
in mitochondrial transmembrane potential (DWm) has been re-
ported to accompany cytochrome c release (Coultas and Strasser,
2003). Chalcones R7 and R13 induced a statistically signiﬁcant in-
crease in cytochrome c release from mitochondria to cytoplasm
(Fig. 6), which is probably related to changes in mitochondrial
membrane potential (DWm) (Winter et al., 2010).
3.7. Chalcones induced calcium concentration and caspase-12 activity
changes
ER stress can be induced by altering calcium concentration with
orwithout the participation of the caspase-12, for this reason the ef-
fect of the three compounds on caspase-12 activity and on calcium
intracellular changes was evaluated. The ionophore A23187 was
used as a control for calcium release. All chalcones induced a large
increase in intracellular calciumconcentration compared to the con-
trol (Fig. 7a), and also increased the caspase-12 activity (Fig. 7b),
indicating that the action of these compounds is related to ER stress.
3.8. Chalcones did not modify the cell cycle
To gain an insight into the mechanism of action of these naph-
thylchalcones, we evaluated their effect on cell cycle distribution.
As can be seen in Fig. 8, exposure of L1210 cells to chalcones forFig. 8. Effect of chalcones on cell cycle distribution. L1210 cells were treated with cha
cytometry, cellular DNA proﬁle was further analyzed using the software WinMDI 2.9. Da
p < 0.01 compared with the control.12 and 24 h did not result in the arrest of G0/G1, S or G2/M phases
of the cell cycle in contrast to Paclitaxel – a mitotic inhibitor used
in cancer chemotherapy, which was used as a positive control in
this study. Paclitaxel induced a statistically signiﬁcant enrichment
of G2-M fraction after 12 and 24 h of incubation.lcones and Paclitaxel for 12 (a) and 24 h (b) and stained with PI. Following ﬂow
ta represent the percentage of cell counts in each cell cycle phase. ⁄ p < 0.05 and ⁄⁄
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to the apoptotic cells. Chalcones R7, R13 and R17 induced an in-
crease of cellular content in this phase, conﬁrming the apoptosis
process evaluated by other methods; Annexin V/PI staining
(Fig. 2) and by caspases activities activation (Fig. 3).
4. Discussion
The development of new drugs for the treatment of cancer is
based on the potential of compounds to block cell proliferation
and/or induce apoptosis (Herr and Debatin, 2001). The anti-CD20
antibody Rituximab and the Bcr-Abl-selective kinase inhibitor Glee-
vec, respectively, are two examples of the success of targeted ther-
apy. Targeting the apoptotic pathways of malignant cells has
become an attractive concept. Apoptosis can be triggered by death
ligands that bind to their death receptors (such as Fas or TRAIL) lo-
cated in the cytoplasmic membrane, leading to the formation of a
minimally homotrimeric ligand–receptor complex. Subsequently,
this complex recruits further cytosolic factors, such as caspase-8,
forming an oligomeric death-inducing signaling complex (DISC),
which then cleaves and activates the effector caspase-3 (Kiechle
and Zhang, 2002; Nakata et al., 2004). The death receptors, mainly
TRAIL, have been shown to induce apoptosis selectively inmany tu-
mor cell lines, such as blood cancers, without affecting normal cells
and tissues. A large number of human tumor cells have shownTRAIL
resistance, and the TRAIL sensitization can induce the apoptosis of
cancer cells (Ashkenazi and Herbst, 2008; Nakata et al., 2004). All
chalcones tested induced an increase in caspase-8 activity (Fig. 3)
and Fas expression (Fig. 4), and may therefore represent an impor-
tant strategy for the treatment of TRAIL resistant cancer cells.
Apoptosis can be triggered in response to a wide range of death
stimuli that are generated from the inside of cells, such as onco-
gene activation and DNA damage. The intrinsic pathway is medi-
ated by mitochondria, and in response to apoptotic stimuli,
several proteins are released from the intermembrane space of
mitochondria into the cytoplasm. Some of the well-characterized
proteins include cytochrome c, SMAC/DIABLO, AIF, EndoG and
Bcl2-family proteins. Cytochrome c binds to the protein APAF1
and induces a conformational change that allows APAF1 to bind
to ATP/dATP and to form the apoptosome, which mediates the acti-
vation of caspase-9, thereby triggering a cascade of caspase activa-
tion (Riedl and Shi, 2004; Sayers, 2011).
The majority of chemotherapies induce the intrinsic apoptosis,
however the crosstalk between the extrinsic and intrinsic apopto-
sis pathway can result in a synergic and efﬁcient induction of cell
death. This synergy between the death receptor and the mitochon-
drial pathway has been observed in several cancer cells, including
blood cancers (Nakata et al., 2004; Ray and Almasan, 2003).
The three chalcones evaluated induced an increase in caspase-9
activity, suggesting an engagement of the intrinsic pathway
(Fig. 3). However, only chalcones R7 and R13 altered the Bcl2-
family proteins expression (Figs. 4 and 5) and an increase in
cytochrome c release (Fig. 6). Chalcone R15 did not change the
Bcl2-family proteins expression (Figs. 4 and 5). For this reason,
we suggest that chalcones R7 and R13 act via different cell death
mechanisms compared to R15. In a previous work already men-
tioned, we also showed that the Chalcones R7 and R13 decreased
the mitochondrial membrane potential and ATP concentration in
L1210 cells (Winter et al., 2010). These previous results are in
agreement with the results shown here, because R7 and R13
decreased the anti-apoptotic Bcl-2, increased the pro-apoptotic
Bax and Bak expression (Fig. 4), and increased cytochrome c
release, which are related to the mitochondrial damage and to
the intrinsic pathway. These two chalcones also induced an
increase in caspase-8 activity (Fig. 3) and Fas expression (Fig. 4),
indicating the engagement of the extrinsic pathway beyond theintrinsic pathway. The link between the two pathways is made
by Bid, a protein that is activated after caspase-8-mediated cleav-
age (Billen et al., 2008; Li and Yuan, 1998). The chalcones R7 and
R13 induced an increase in Bid expression (Fig. 4).
Although the synergistic effect of apoptosis by combined
treatment of extrinsic and intrinsic apoptosis is well established,
their underlying mechanisms are not completely understood
(Schneider-Jakob et al., 2010).
Many mutations related to the source of cancer, such as loss of
proapoptotic factors like p53 and Bax or the overexpression of anti-
apoptotic factors like Bcl-2 and Mcl-1, reduce intrinsic apoptosis
signaling and thus prevent the efﬁcient elimination of transformed
cells. Furthermore, standard chemotherapy and radiotherapy for
cancer predominantly initiate apoptosis via the intrinsic pathway
and thus might positively select cancer cells, which can evade
intrinsic apoptosis signaling (Sayers, 2011). As the Chalcones R7
and R13 studied here induced the extrinsic and the intrinsic path-
ways concomitantly, decreasing anti-apoptotic like Bcl-2 and
increasing pro-apoptotic factor Bax and cytochrome c, they can
be considered important as a strategy for cancer treatment. These
compounds could achieve the intrinsic pathway-resistant cancer
cells and those cells that present mutation in apoptosis-related fac-
tors. Conversely, Dou et al. showed that the apoptosis induced in a
leukemic cell line (HL60) was also via both intrinsic and extrinsic
pathways, however they did not evaluate the possible changes in
Bid (Dou et al., 2011), while Kim et al. demonstrated that the effect
of the ﬂavonoid genistein on cervical cancer cells is through intrin-
sic and extrinsic apoptosis pathways by an increase in Bax, a de-
crease in Bcl-2 and the activation of Bid (Kim et al., 2009).
In addition, it was also shown in our previous study that Chal-
cone R15 induced a strong ROS generation and did not change the
mitochondrial membrane potential in L1210 cells (Winter et al.,
2010). In this work, it was observed that R15 did not change the
Bcl2-family proteins and Bid expression (Fig. 4). The cell death trig-
gered by R15 also was attended by caspases 8 and 9 (Fig. 3), but it
does not seem to be related to mitochondrial damage. The increase
of caspase-9 can possibly be related to the ER stress induced by
R15, because this compound did not induce the cytochrome c
release.
The transcription factor p53 suppresses tumorigenesis and is di-
rectly mutated in over 50% of tumors. In the other 50% of cases,
the gene of p53 itself is not mutated, however the gene p53 path-
way is often partially inactivated (Cheok et al., 2011). In addition,
the mutation of the p53 gene is related to a poor clinical outcome
in childhood ALL (Kawamura et al., 1999). Usually, the studies aim
to increase the p53 expression and to induce the apoptosis of the
cancer cells (Liu et al., 2008; Martinez-Rivera and Siddik, 2012).
In this study we found that the chalcones, mainly the R15, de-
creased the p53 protein expression. Although seemingly contro-
versial at ﬁrst sight, this effect deserves further studies, as it
could be an important strategy for the treatment of patients who
exhibit a p53-mutated tumor.
All three chalcones induced an increase in calcium concentra-
tion (Fig. 7a), caspase-12 activity (Fig. 7b) and CHOP expression
(Fig. 4), indicating that these compounds lead to ER stress. The
ER plays a key role in maintaining intracellular Ca2+ homeostasis,
which directly inﬂuences protein folding and subsequently ER
stress and apoptosis. The ER stress occurs when there is over pro-
duction and accumulation of misfolded proteins, or in a situation of
altered calcium homeostasis (Berridge, 2002). The result of pro-
longed ER stress can be the apoptosis activation through different
mechanisms. One of the components of the ER stress is C/EBP
homologous protein (CHOP) also known as GADD153. Elevated lev-
els of CHOP leads to alterations in gene transcription involved with
apoptosis as inhibition of anti-apoptotic Bcl-2, stimulation of death
receptor 5 (DR5), increase of pro-apoptotic protein Bim, caspases
776 E. Winter et al. / Toxicology in Vitro 28 (2014) 769–777activation and mitochondrial events (Oyadomari and Mori, 2004;
Schonthal, 2013). The caspase-12 is the main caspase involved in
ER stress and after activation can activate the caspase-9, and
consequently the caspase-3 (Groenendyk and Michalak, 2005;
Nakagawa et al., 2000). Studies have been shown compounds with
antitumoral activity inducing ER stress by CHOP similarly to chal-
cones studied in this work (Choi et al., 2013; Gills et al., 2007;
Lovat et al., 2003; Sanchez-Lopez et al., 2013).
Most anticancer agents exhibit their inhibitory effects on tumor
cell growth by inducing cell cycle arrest and apoptosis. Recent re-
ports have demonstrated that chalcones induce cell cycle arrest in
different cancer cell lines (Hsu et al., 2006; Mielcke et al., 2012; Rao
et al., 2010). None of the compounds induced cell cycle arrest in
this work (Fig. 8). This lack of effect on the cell cycle may be related
to the strong decrease in p21 expression. The p21 protein is regu-
lated by the p53 gene, and is best known for its ability to regulate
the cell cycle (Sherr, 1996; Vermeulen et al., 2003). However, p21
has been classiﬁed as an anti-apoptotic protein that can inhibit the
caspase-3 activation (Dotto, 2000; Suzuki et al., 2000). High
expression of p21 can lead cells to display apoptosis resistance
(Asada et al., 1999). The decrease of p21 expression caused by
Chalcones R7, R13 and R15 probably promoted apoptosis, but not
via the cell cycle arrest.
In conclusion, our study suggests that the Chalcones R7, R13
and R15 induced apoptosis by different mechanisms in a leukemic
cell line and presented higher selectivity for leukemic cells than for
non-tumoral cells. The mechanism of action of Chalcones R7 and
R13 is related to mitochondrial signaling, to trigger the extrinsic
and the intrinsic apoptosis pathways, which can be an advantage
for the treatment of intrinsic pathway-resistant tumors, and also
to ER stress. On the other hand, Chalcone R15 triggered the apop-
tosis by extrinsic pathway and ER stress. These results indicate that
the compounds studied are promising in the research of new drugs
for cancer treatment because they induce a minimum of two apop-
tosis pathways what could help to circumvent possible cancer cell
strategies of resistance.Conﬂict of Interest
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